Pricing
  1. US-listed companies
  2. IDEXX LABORATORIES INC
  3. Financials
  4. Capital expenditures

IDEXX LABORATORIES INC (IDXX)

Market cap
$45.8B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-121-9.51%
Dec 31, 2023-134-10.22%
Dec 31, 2022-149+24.50%
Dec 31, 2021-120+11.77%
Dec 31, 2020-107-30.98%
Dec 31, 2019-155+33.88%
Dec 31, 2018-116+55.61%
Dec 31, 2017-74+14.81%
Dec 31, 2016-65-21.87%
Dec 31, 2015-83+37.01%
Dec 31, 2014-61-22.02%
Dec 31, 2013-78+18.51%
Dec 31, 2012-65+24.83%
Dec 31, 2011-52+34.84%
Dec 31, 2010-39

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat